What's Happening?
Bruker Corporation has launched the MyGenius PRO, a high-throughput molecular diagnostics system at ESCMID 2026. The system automates the entire workflow from sample to diagnostic result, enhancing laboratory efficiency. It supports continuous loading
and random-access operation, with assays for viruses like CMV and EBV. The platform was developed in collaboration with ELITechGroup and Hitachi High-Tech, aiming to improve turnaround time and infection monitoring in microbiology labs.
Why It's Important?
The MyGenius PRO system represents a significant advancement in molecular diagnostics, offering high-throughput capabilities that improve laboratory productivity and diagnostic accuracy. By automating processes, the system reduces manual intervention, supporting faster clinical responses and effective infection monitoring. This innovation is crucial for microbiology labs facing increasing demands for rapid and reliable diagnostics, potentially improving patient outcomes and streamlining healthcare operations.
